Clinical trials sponsored by First Affiliated Hospital of Zhejiang University

Phase breakdown

Conditions studied

Recruiting trials led by First Affiliated Hospital of Zhejiang University

• A Study on the Efficacy and Safety of Oral All-trans Retinoic Acid Combined With Toripalimab in TNBC.
  NCT06371274 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 1 location
• Accelerated Intermittent Theta-Burst Stimulation Ameliorate Major Depressive Disorder by Regulating CAMKII Pathway
  NCT05913960 · Phase: Not applicable (e.g. observational or device study) · Ages: 12 Years to 45 Years · Sex: All (male and female) · 1 location
• An Observational Study on Lecanemab Treatment for Early Alzheimer's Disease
  NCT07153848 · Phase: Not specified · Ages: 45 Years to 85 Years · Sex: All (male and female) · 2 locations
• Bortezomib Combined with PD-1 MAb and MFOLFIRINOX for Metastatic Pancreatic Cancer
  NCT06572813 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Chinese Longitudinal and Systematic Study of Bioplar Disorder
  NCT05480150 · Phase: Not applicable (e.g. observational or device study) · Ages: 16 Years to 65 Years · Sex: All (male and female) · 1 location
• Construction and Clinical Application of the Immune Map of Pancreatic Cancer Evolution
  NCT07034339 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Effects of Repetitive Transcranial Magnetic Stimulation in Patients With Alzheimer's Disease
  NCT06385106 · Phase: Not applicable (e.g. observational or device study) · Ages: 55 Years to 80 Years · Sex: All (male and female) · 1 location
• Efficacy and Safety Assessment of Temporal Interference Stimulation to Improve Bipolar Depression
  NCT07021508 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 45 Years · Sex: All (male and female) · 1 location
• Efficacy and Safety of Modified Si Jun Zi Tang in Perioperative NSCLC Treatment
  NCT06445881 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Immunoprofilling of Peripheral Blood Mononuclear Cells in Children With Attention Deficit/Hyperactivity Disorder
  NCT06109337 · Phase: Not specified · Ages: 6 Years to 12 Years · Sex: All (male and female) · 1 location
• MR Microstructural Imaging for Prostate Cancer Diagnosis
  NCT07249281 · Phase: Not specified · Ages: No age limits stated · Sex: Male · 6 locations
• Neoadjuvant Chemotherapy Combined With Sintilimab and Bevacizumab for TNBC (NEOTORCH-BREAST07)
  NCT07351487 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: Female · 2 locations
• Neoadjuvant Chemotherapy Plus Pyrotinib and Trastuzumab for HER2-positive Breast Cancer (NEOTORCH-BREAST05)
  NCT06832904 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: Female · 1 location
• Neoadjuvant Chemotherapy in Combination With Anlotinib and Benmelstobart for HR+/HER2- Breast Cancer (NEOTORCH-BREAST03)
  NCT06874933 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: Female · 3 locations
• Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer (NEOTORCH-BREAST01)
  NCT06611813 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: Female · 11 locations
• Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer : a Randomized, Open-label, Parallel-controlled, Multi-center Phase III Study (NEOTORCH-BREAST04)
  NCT06977893 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: Female · 13 locations
• Radiotherapy Followed by Chemotherapy Combined With Toripalimab in Local Advanced HR-positive,HER2-negative BC.
  NCT06705127 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Research on the Efficacy and Safety of Targeted Suprachiasmatic Nucleus Electrical Stimulation for Improving Metabolic Disorders in Patients With Stable Bipolar Disorder Comorbid With Obesity
  NCT07589647 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 45 Years · Sex: All (male and female) · 1 location
• Study of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumors.
  NCT04778839 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 2 locations
• The Mechanisms of Underlying Accelerated Repetitive Transcranial Magnetic Stimulation for Treatment-resistant Depression
  NCT05607654 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 45 Years · Sex: All (male and female) · 1 location
• The Peripheral Blood Multi-Omics Study on Sleep Loss
  NCT06492109 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location

Common questions

How many trials is First Affiliated Hospital of Zhejiang University recruiting for?

First Affiliated Hospital of Zhejiang University is the lead sponsor of 21 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.